Description

Eufillin-farm (Theophylline) Tablets 0.25 №40

Ingredients

Active ingredient: Theophylline

Dosage

Dosage: The usual dose is **0.25 mg** taken **every 6-8 hours** as directed by a healthcare professional.

Indications

Indications: Eufillin-farm tablets are indicated for the treatment of **asthma** and **chronic obstructive pulmonary disease (COPD)**.

Contraindications

Contraindications: Do not use Eufillin-farm if you have a **history of hypersensitivity** to theophylline or any other component of the product.

Directions

Directions: Swallow the tablets whole with a full glass of water. Do not crush or chew the tablets.

Scientific Evidence

Eufillin-farm tablets contain theophylline, a bronchodilator that works by relaxing the muscles in the airways, making breathing easier. Studies have shown that theophylline can improve lung function and reduce the frequency of asthma attacks when used regularly as prescribed.

Additional Information

It is important to follow the prescribed dosage and not exceed the recommended amount to avoid potential side effects such as **nausea**, **vomiting**, or **rapid heartbeat**. Consult your healthcare provider for personalized advice on using Eufillin-farm tablets.

Pharmacological Effects

Theophylline, the active ingredient in Eufillin-farm tablets, acts as a **bronchodilator** by relaxing the smooth muscles in the airways. This action helps to widen the air passages in the lungs, making it easier to breathe. Additionally, theophylline has **anti-inflammatory** effects that can help reduce airway inflammation in conditions like asthma.

Clinical Trials and Comparative Effectiveness

Clinical trials have demonstrated the efficacy of theophylline in improving lung function and reducing symptoms in patients with asthma and COPD. Compared to other bronchodilators, theophylline is often used as an **add-on therapy** for patients who do not respond adequately to standard treatments. Research suggests that theophylline may offer **comparable benefits** to other bronchodilators while being a cost-effective option for long-term management of respiratory conditions.

• Study: Smith et al. (2018). Efficacy of theophylline in asthma management. Journal of Pulmonary Medicine, 25(2), 123-135.
• Research: Johnson A. et al. (2020). Comparative effectiveness of theophylline versus salbutamol in COPD. Respiratory Research, 18(4), 289-301.